Hear from our Chief Scientific Officer, Amanda Tulk, about recent case studies by Dr. Gerald Fogarty. Dr. Fogarty used superficial radiotherapy to treat lesions of the ear, lips and eyelids. https://vimeo.com/718008005
Resources
Contact Us
Hear from our Chief Scientific Officer, Amanda Tulk, about recent case studies by Dr. Gerald Fogarty. Dr. Fogarty used superficial radiotherapy to treat lesions of the ear, lips and eyelids. https://vimeo.com/718008005
Oncology is one of the main growing specialties in small animal medicine with a high number of cases and wider availability of CT scanning. Radiation therapy is part of numerous cancer treatment protocols but still mostly unavailable. Orthovoltage radiation provides a...
The majority of radiobiology studies follow a classic linear research pathway — from laboratory-based research to preclinical studies that can lead to clinical trials. Researchers at Queen’s University Belfast are beginning to challenge this approach by reverse...
In this video with our Chief Scientific Officer, Amanda Tulk, you can learn about some of the important pieces of setting up a good radiotherapy skin practice and see how Dr. Gerald Fogarty has been able to successfully treat a range of patients....
It can be difficult to treat non-melanoma skin cancer (NMSC) of the lower legs. The blood supply of the lower legs makes surgery challenging, and radiotherapy below the knee is controversial because of the fear of radiation-induced ulcers. In the study, "Lesion-based...
Hear from our CEO, Adrian Treverton, about treating non-melanoma skin cancer patients safely during COVID. Patients most likely to develop basal or squamous cell carcinoma are those in the age range at greater risk of serious illness from COVID, so safe and short...
One common question dermatologists often ask about incorporating radiation therapy into their practice is “How much involvement do I need from a radiation oncologist?” Regulations concerning physician supervision, reimbursement, and radiation shielding can vary quite...
In the published study, "Split Course Superficial Radiotherapy in Scrotal Extramammary Paget’s Disease Allows Course Completion With Minimal Side Effects: A Case Study" by Gerald B. Fogarty, et al., the Xstrahl 300 system was used to treat Paget's disease to a...
Hear from Xstrahl's CEO, Adrian Treverton, on the future of skin cancer treatment. https://vimeo.com/718012693
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |